Myovant Sciences Pre-Tax Profit Margin 2017-2022 | MYOV
Myovant Sciences pre-tax profit margin from 2017 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
|Myovant Sciences Pre-Tax Profit Margin Historical Data
||TTM Pre-Tax Income
||Medical - Biomedical and Genetics
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.